Browse
Explore conditions, clinical trials, and the organisations running them.
Find a condition
Search the conditions that have clinical trials.
7595 conditions with clinical trials.
- Central nervous system non-hodgkin lymphoma 1 trial · 3,323 incl. sub-types
- Liver lymphoma 1 trial · 3,318 incl. sub-types
- Indolent primary cutaneous B-cell lymphoma 1 trial · 3,298 incl. sub-types
- Primary cutaneous marginal zone B-cell lymphoma 1 trial · 3,297 incl. sub-types
- Gastric lymphoma 1 trial · 3,281 incl. sub-types
- Retina lymphoma 1 trial · 3,281 incl. sub-types
- Primary lymphoma of the conjunctiva 1 trial · 3,268 incl. sub-types
- Primary bone lymphoma 1 trial · 3,256 incl. sub-types
- Mixed phenotype acute leukemia, B/myeloid 1 trial · 3,246 incl. sub-types
- Childhood brain stem glioma 1 trial · 3,228 incl. sub-types
- Mycosis fungoides variant 1 trial · 3,224 incl. sub-types
- Granulomatous slack skin disease 1 trial · 3,222 incl. sub-types
- Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma 1 trial · 3,221 incl. sub-types
- Primary cutaneous gamma/delta-positive T-cell lymphoma 1 trial · 3,221 incl. sub-types
- Primary cutaneous peripheral T-cell lymphoma not otherwise specified 1 trial · 3,221 incl. sub-types
- Indolent plasma cell myeloma 1 trial · 3,210 incl. sub-types
- Non-secretory plasma cell myeloma 1 trial · 3,210 incl. sub-types
- Inherited acute myeloid leukemia 1 trial · 3,203 incl. sub-types
- Krukenberg carcinoma 1 trial · 3,184 incl. sub-types
- Acute myeloid leukemia and myelodysplastic syndromes related to radiation 1 trial · 3,181 incl. sub-types
- Acute myeloid leukemia, biallelic CEBPA gene mutation 1 trial · 3,180 incl. sub-types
- Acute myeloid leukemia, FLT3 tyrosine kinase domain point mutation 1 trial · 3,180 incl. sub-types
- Acute myeloid leukemia, t(v;11q23.3) 1 trial · 3,180 incl. sub-types
- Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 1 trial · 3,180 incl. sub-types
- Acute myeloid leukemia with CBFA2T3-GLIS2 fusion 1 trial · 3,180 incl. sub-types
- Acute myeloid leukemia with CEBPA somatic mutations 1 trial · 3,180 incl. sub-types
- Acute myeloid leukemia with t(6;9)(p23;q34) 1 trial · 3,180 incl. sub-types
- Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) 1 trial · 3,180 incl. sub-types
- Acute myeloid leukemia, t(15;17)(q24;q21) 1 trial · 3,179 incl. sub-types
- Heart lymphoma 1 trial · 3,179 incl. sub-types
- Mediastinal gray zone lymphoma 1 trial · 3,178 incl. sub-types
- Metastatic malignant neoplasm in the eye 1 trial · 3,170 incl. sub-types
- Childhood malignant schwannoma 1 trial · 3,162 incl. sub-types
- Myelofibrosis with myeloid metaplasia 1 trial · 3,162 incl. sub-types
- Pediatric infratentorial ependymoma 1 trial · 3,143 incl. sub-types
- Salivary gland basal cell adenocarcinoma 1 trial · 3,099 incl. sub-types
- Childhood immature teratoma of ovary 1 trial · 3,096 incl. sub-types
- Childhood choroid plexus carcinoma 1 trial · 3,093 incl. sub-types
- Pineal region yolk sac tumor 1 trial · 3,091 incl. sub-types
- Childhood brain germinoma 1 trial · 3,086 incl. sub-types
- Maxillary sinus squamous cell carcinoma 1 trial · 3,080 incl. sub-types
- Liver sarcoma 1 trial · 3,079 incl. sub-types
- Childhood oligodendroglioma 1 trial · 3,076 incl. sub-types
- Maxillary sinus carcinoma 1 trial · 3,073 incl. sub-types
- Carcinoma in situ of nasopharynx 1 trial · 3,071 incl. sub-types
- Extrarenal rhabdoid tumor 1 trial · 3,070 incl. sub-types
- Gingival cancer 1 trial · 3,068 incl. sub-types
- Carcinoma in situ of oropharynx 1 trial · 3,067 incl. sub-types
- Oral cavity mucoepidermoid carcinoma 1 trial · 3,062 incl. sub-types
- Tonsil carcinoma 1 trial · 3,061 incl. sub-types